Business Context and Reporting Period
This Form 6-K filing by Nanobiotix S.A. covers the reporting period of May 15, 2025. The document serves as a notification of transactions by Persons Discharging Managerial Responsibilities (PDMR) and closely associated persons, filed in compliance with the EU Market Abuse Regulation (MAR).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a regulatory disclosure regarding insider transactions and does not contain financial performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely discloses the occurrence of PDMR transactions as required by law.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, or discussion of risks and contingencies. The only disclosed item is the attachment of PDMR notifications (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 for specific details on the nature and volume of PDMR transactions.
- Verify the identity of the specific managers or associated persons involved in the disclosed transactions.
- Confirm that no other material events were omitted from this specific notification.